Genomic Health, Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. The company offers Oncotype DX breast cancer test, which the multigene expression test that has clinical evidence validating its ability to predict the likelihood of chemotherapy benefit, as well as recurrence in early-stage breast cancer. In addition to its adopted Oncotype DX breast cancer test, Genomic Health also offers its Oncotype DX colon cancer test.
The company was founded in 2000 and is based in Redwood City, California.
Current Team (5)Update
Board Members and Advisors (3)Update
101 Galveston Drive
Redwood City, CA 94063